SGB-3252

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameSGB-3252
Drug Alias NameSGB-3252
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionPlasminogen inhibitors
TargetsPlasminogen
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Sanegene Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Sanegene Bio Inc
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A